Column GROUP Ii, L.P., 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 126,478 shares at $11.29 ($1.4M) on 2019-10-18, disclosed to the SEC on 2019-10-21.
Open-market purchase of $1.4M NGM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.62 | 6,818 | $72K | 5.0% |
| 2 | $10.62 | 6,818 | $72K | 5.0% |
| 3 | $11.29 | 34,721 | $392K | 27.1% |
| 4 | $11.29 | 34,721 | $392K | 27.1% |
| 5 | $11.94 | 43,400 | $518K | 35.8% |
| Total | $11.44 avg | 126,478 |
| $1.4M |
| 100% |
| Filing → |
| RAPT | SELL | 2021-09-16 | $13.0M | — | Filing → |
| NGM | BUY | 2019-08-09 | $3.1M | — | Filing → |
| NGM | BUY | 2019-05-13 | $496K | — | Filing → |